Physician profile
Jeffrey Mitchell Blackmon
NPI 1710901996
$1,260.60
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $74.92 · 2021: $490 · 2022: $368 · 2023: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $232.59 | 2019-2023 | |
| Abbvie INC. | $152.20 | 2021-2023 | Ubrelvy |
| Glaxosmithkline, LLC. | $105.81 | 2020-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $101.66 | 2021-2022 | |
| Lilly USA, LLC | $74.14 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.57 | 2021 | |
| Esperion Therapeutics, INC. | $62.69 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $56.04 | 2022-2023 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.41 | 2021-2023 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $45.54 | 2022 | |
| Merck Sharp & Dohme LLC | $44.24 | 2020-2021 | |
| Amarin Pharma, INC. | $43.57 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $33.59 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $32.82 | 2021-2023 | Rexulti |
| Mylan Specialty L.P. | $26.57 | 2023 | Yupelri |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.37 | 2022 | |
| Horizon Therapeutics Plc | $20.75 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.61 | 2023 | Austedo |
| Portola Pharmaceuticals, LLC | $18.01 | 2019 | |
| Exact Sciences Corporation | $14.87 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $14.61 | 2019 | |
| Radius Health, INC. | $13.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Blackmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.